Susan Froshauer
Advisors
External Advisory Committe
Office of Therapeutics Alliances
India
Biography
Dr. Froshauer is President and CEO of Connecticut United for Research Excellence (CURE), the bioscience association of the state of Connecticut. She is an experienced scientist, mentor, entrepreneur and investor with skill at connecting academic expertise and technology with the commercial sector. Prior to joining CURE, she was director of the Technology Exchange Portal at the University of Connecticut's Office of Economic Development. Until 2010, Dr. Froshauer served as President and CEO of Rib-X Pharmaceuticals, which she co-founded in New Haven in 2000. Under her leadership, Rib-X raised more than $160 million in private equity, bridge financing and government grants and built a robust pipeline of antibiotics to treat serious hospital infections. Prior to Rib-X, Dr. Froshauer served as a member of Pfizer's Strategic Alliance Group where she was key to the creation of a $200 million investment portfolio that transformed the Pfizer global research and development strategy, helping the company identify new resources for drug discovery. Dr. Froshauer received her PhD in microbiology and molecular genetics from Harvard University and a BA from Connecticut College. She performed post-doctoral research at Yale Medical School in the Department of Cell Biology as a Jane Coffin Child's Fellow.
Research Interest
Molecular Biology, Cell Biology, Business Management